TITLE

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus

AUTHOR(S)
de la Poza, Francisco; Calvo-Pinilla, Eva; López-Gil, Elena; Marín-López, Alejandro; Mateos, Francisco; Castillo-Olivares, Javier; Lorenzo, Gema; Ortego, Javier
PUB. DATE
July 2013
SOURCE
PLoS ONE;Jul2013, Vol. 8 Issue 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
African horse sickness virus (AHSV) belongs to the genus Orbivirus. We have now engineered naked DNAs and recombinant modified vaccinia virus Ankara (rMVA) expressing VP2 and NS1 proteins from AHSV-4. IFNAR(−/−) mice inoculated with DNA/rMVA-VP2,-NS1 from AHSV-4 in an heterologous prime-boost vaccination strategy generated significant levels of neutralizing antibodies specific of AHSV-4. In addition, vaccination stimulated specific T cell responses against the virus. The vaccine elicited partial protection against an homologous AHSV-4 infection and induced cross-protection against the heterologous AHSV-9. Similarly, IFNAR(−/−) mice vaccinated with an homologous prime-boost strategy with rMVA-VP2-NS1 from AHSV-4 developed neutralizing antibodies and protective immunity against AHSV-4. Furthermore, the levels of immunity were very high since none of vaccinated animals presented viraemia when they were challenged against the homologous AHSV-4 and very low levels when they were challenged against the heterologous virus AHSV-9. These data suggest that the immunization with rMVA/rMVA was more efficient in protection against a virulent challenge with AHSV-4 and both strategies, DNA/rMVA and rMVA/rMVA, protected against the infection with AHSV-9. The inclusion of the protein NS1 in the vaccine formulations targeting AHSV generates promising multiserotype vaccines.
ACCESSION #
89628873

 

Related Articles

  • Influenza Nucleoprotein Delivered with Aluminium Salts Protects Mice from an Influenza A Virus That Expresses an Altered Nucleoprotein Sequence. MacLeod, Megan K. L.; David, Alexandria; Jin, Niyun; Noges, Laura; Wang, Jieru; Kappler, John W.; Marrack, Philippa // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Influenza virus poses a difficult challenge for protective immunity. This virus is adept at altering its surface proteins, the proteins that are the targets of neutralizing antibody. Consequently, each year a new vaccine must be developed to combat the current recirculating strains. A universal...

  • Hepatitis B Precore Protein: Pathogenic Potential and Therapeutic Promise. Walsh, Renae; Locarnini, Stephen // Yonsei Medical Journal;Sep2012, Vol. 53 Issue 5, p875 

    Hepatitis B virus (HBV), a small and economically packaged double-stranded DNA virus, represents an enormous global health care burden. In spite of an effective vaccine, HBV is endemic in many countries. Chronic hepatitis B (CHB) results in the development of signiicant clinical outcomes such as...

  • Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice. Chapman, Rosamund; Stutz, Helen; Jacobs Jr, William; Shephard, Enid; Williamson, Anna-Lise // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    In previous studies we have shown that a pantothenate auxotroph of Myocbacterium bovis BCG (BCGΔpanCD) expressing HIV-1 subtype C Gag induced Gag-specific immune responses in mice and Chacma baboons after prime-boost immunization in combination with matched rMVA and VLP vaccines...

  • Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice. Fontana, Judith M.; Christos, Paul J.; Michelini, Zuleika; Negri, Donatella; Cara, Andrea; Salvatore, Mirella // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Recent reports highlight the potential for integrase-defective lentiviral vectors (IDLV) to be developed as vaccines due to their ability to elicit cell-mediated and humoral immune responses after intramuscular administration. Differently from their integrase-competent counterpart, whose utility...

  • Avian Influenza Virus Could Kill Millions.  // USA Today Magazine;Dec2005, Vol. 134 Issue 2727, p16 

    The article provides information on a study being conducted by Suresh Mittal, molecular virologist at Purdue University, West Lafayette, Indiana and his collaborators on a way to provide immunity against avian influenza viruses or bird flu in 2005. Adenovirus is to be used in the research as a...

  • Vaccines: Engineering immune evasion. Mascola, John R. // Nature;5/11/2006, Vol. 441 Issue 7090, p161 

    The article focuses on the approach to the molecular engineering of the recombinant adenovirus vectors (rAd5). rAd5 has the potential to circumvent anti-vector immunity. The author also provides proof-of-concept that viral vaccine vectors can be engineered to evade pre-existing immunity. The...

  • Elements: in this month's issue. Bannon, Michael // QJM: An International Journal of Medicine;Jan2012, Vol. 105 Issue 1, p1 

    No abstract available.

  • Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is Endemic. Durbin, Anna P.; Schmidt, Alexander; Elwood, Dan; Wanionek, Kimberli A.; Lovchik, Janece; Thumar, Bhavin; Murphy, Brian R.; Whitehead, Stephen S. // Journal of Infectious Diseases;2/1/2011, Vol. 203 Issue 3, p327 

    Background. Because infection with any of the 4 Dengue virus serotypes may elicit both protective neutralizing antibodies and nonneutralizing antibodies capable of enhancing subsequent heterotypic Dengue virus infections, the greatest risk for severe dengue occurs during a second, heterotypic...

  • Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells. Kamran, Neha; Takai, Yoshimi; Miyoshi, Jun; Biswas, Subhra K.; Wong, Justin S. B.; Gasser, Stephan // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Genotoxic stress and RAS induce the expression of CD155, a ligand for the immune receptors DNAM-1, CD96 and TIGIT. Here we show that antigen-presenting cells upregulate CD155 expression in response to Toll-like receptor activation. Induction of CD155 by Toll-like receptors depended on MYD88,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics